| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |